Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Bob L who wrote (7256)	12/4/1999 10:28:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 9719

Yeah, Bob. I was joking. Was suggesting that it was either (1) an issue of nodes taking awhile to return to something that could be classified as a CR, despite no real difference in the percentage of cells that are transformed, or (2) anti-id. Everyone will realize that I'm really stretching for #2, but, hey, it's fun. I am a big believer in widely differing affinities for anti-ids, so one anti-CD20 need not be the same as the next in my never-never land.